premieranalysis

premieranalysis

The price was still rejected at the support of 31 usd. I believe it is time to buy, especially for the following reasons: Palantir Announces that results for its fourth quarter and fiscal year ended December 31, 2020 will be released on Tuesday, February 16, 2021, prior to the U.S. Open. markets. The Company will host a conference call to discuss its results at...

premieranalysis Updated 

If the price breaks the support at 3.53 then we can buy at 2.93 Target : 4.60

premieranalysis Updated 

price pullback to 1.77 , wait confirmation and strong BUY to 15

premieranalysis Updated 

AzurRx BioPharma Announces Completion of Enrollment in First Cohort of Phase 2b OPTION 2 Extension Study of MS1819 AZRX broke the support from 1.72 to 1.46 (61.8% fibo). If the decline continues, then buy at 1.20. Trigger: Waiting for a momentum candle close below the gray area to buy. Good luck!